Scholarlink

Background <p>Per- and polyfluoroalkyl substances (PFASs), particularly perfluorooctanoic acid (PFOA) and perfluorooctanesulfonic acid (PFOS), are persistent environmental pollutants increasingly implicated in bone metabolic disturbances, yet their roles in skeletal physiology and pathology remain insufficiently defined.</p> Objective <p>To systematically evaluate the potential biological effects of PFOA and PFOS on a broad spectrum of bone-related physiological and clinical traits.</p> Methods <p>Using large-scale genomic data from European-ancestry cohorts, we applied a two-sample Mendelian Randomization approach to assess the causal impact of genetically predicted PFAS exposure on bone phenotypes, complemented by sensitivity analyses and reverse-direction testing. Mediation analyses were performed to explore potential biological pathways.</p> Results <p>Genetically predicted PFAS exposure was associated with significant alterations in bone physiological markers. Higher PFOA levels were linked to increased parathyroid hormone–related protein and collagen alpha-1(XX) chain, whereas PFOS was associated with elevated parathyroid hormone and reduced calcaneal bone density. PFOA also demonstrated causal relationships with multiple skeletal pathologies, including osteonecrosis, benign bone tumors, and spine fractures. Results were consistent across sensitivity analyses, and reverse MR analyses did not support reverse causality.</p> Conclusion <p>This study provides robust genetic evidence that PFAS exposure adversely affects bone metabolism and skeletal health. These findings underscore PFASs as potentially modifiable environmental risk factors for bone disorders and highlight mechanistic pathways that merit further experimental and cross-ancestry investigation.</p> Graphical Abstract <p></p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

A genomic framework for evaluating the impact of per- and polyfluoroalkyl substances on bone health

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年1月3日

查看全文
  • Sixuan Liu,
  • Senlin Luo,
  • Xiaokun Zhao,
  • Yinhuai Wang,
  • Yi Peng,
  • Jiachen Liu,
  • Haiqing He

摘要

Background

Per- and polyfluoroalkyl substances (PFASs), particularly perfluorooctanoic acid (PFOA) and perfluorooctanesulfonic acid (PFOS), are persistent environmental pollutants increasingly implicated in bone metabolic disturbances, yet their roles in skeletal physiology and pathology remain insufficiently defined.

Objective

To systematically evaluate the potential biological effects of PFOA and PFOS on a broad spectrum of bone-related physiological and clinical traits.

Methods

Using large-scale genomic data from European-ancestry cohorts, we applied a two-sample Mendelian Randomization approach to assess the causal impact of genetically predicted PFAS exposure on bone phenotypes, complemented by sensitivity analyses and reverse-direction testing. Mediation analyses were performed to explore potential biological pathways.

Results

Genetically predicted PFAS exposure was associated with significant alterations in bone physiological markers. Higher PFOA levels were linked to increased parathyroid hormone–related protein and collagen alpha-1(XX) chain, whereas PFOS was associated with elevated parathyroid hormone and reduced calcaneal bone density. PFOA also demonstrated causal relationships with multiple skeletal pathologies, including osteonecrosis, benign bone tumors, and spine fractures. Results were consistent across sensitivity analyses, and reverse MR analyses did not support reverse causality.

Conclusion

This study provides robust genetic evidence that PFAS exposure adversely affects bone metabolism and skeletal health. These findings underscore PFASs as potentially modifiable environmental risk factors for bone disorders and highlight mechanistic pathways that merit further experimental and cross-ancestry investigation.

Graphical Abstract